When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S147330992600424X?dgcid=rss_sd_all
When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S147330992600424X?dgcid=rss_sd_all
“When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside.” The Lancet Infectious Diseases.
@article{article90955,
title = {When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S147330992600424X?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...